When Sanjana Dayal, PhD, and her colleagues met for their weekly “Blood Club” on March 12, 2020, they kickstarted a branch of research that would captivate them for years to come. The club, which discusses all things related to benign hematology, was already seeing the budding effects of the COVID-19 pandemic that would quickly become […]
On the afternoon of Tuesday, February 6, the department’s Staff Engagement Action Committee (SEAC) waited in the Seebohm conference room to welcome more than 30 administrative staff who were being honored for their contributions during the early days of the COVID-19 pandemic. Each person was handpicked by their current or prior supervisor for having gone […]
Assistant Professor in General Internal Medicine, Aaron Scherer, PhD, is the primary investigator (PI) for a large, cooperative agreement with the Centers for Disease Control and Prevention (CDC) to conduct surveys on immunization-related issues with health care professionals and the general public. His and his team’s work help inform the CDC’s Advisory Committee on Immunization […]
The beginning of June represents the home stretch for the academic year. This month will be filled with a number of transitions, most notably our residency and fellowship graduations. At the end of this month we will begin the welcoming and onboarding of a new class of interns and more than a few new faculty […]
Three years have passed since the last in-person version of this Continuing Medical Education conference hosted by the Division of Infectious Diseases. That year, 2019, a different pandemic took center stage in the programming as the division celebrated the 30-year anniversary of the founding of the HIV/AIDS Clinic at UI Health Care. It can be […]
Sanjana Dayal, PhD, and Steven Lentz, MD, PhD, received a $3.36M R01 grant from the National Institute of Allergy and Infectious Diseases. The grant, titled “Cellular Effects of SARS-CoV-2 in Mediating Thrombotic Susceptibility,” will allow Dayal and Lentz to investigate whether an increase in cytokines as a result of COVID-19 can activate blood cells and […]
Many of our faculty and staff in the department and at University of Iowa Health Care have been quick to add another role, public advocate, to their educator-researcher-clinician roles over the course of the pandemic. We have always responded to requests for interviews, serving as experts on everything from updated colonoscopy screening guidelines to the […]
After SARS-CoV-2 began to rapidly spread across the globe in 2020, there was a rush to develop safe and effective vaccines that could slow the spread and limit the severity of the virus. Although the mRNA vaccines reduce symptoms of COVID-19 by more than 90%, the efficacy of these mRNA vaccines in immunocompromised people has […]
Thrombosis is commonly associated with COVID-19; however, the impact of enoxaparin, an anti-clotting drug, on COVID-19 remains uncertain. Usha Perepu, MBBS, MRCP, clinical associate professor in Hematology, Oncology, and Blood and Marrow Transplantation, and Isaac Chambers, MD, former Hematology and Medical Oncology chief fellow, conducted a multi-center, open-label, randomized, controlled trial comparing the outcome of […]
Martha Carvour, MD, PhD, has received a three-year, $758K grant from the University of Iowa’s Strategic Initiatives Fund (UISIF) to begin a series of campus- and community-wide projects aimed at improving equity in health science and practice (E-HSP). Funds in the UISIF are generated from the public-private partnership Iowa established in 2019 and are to […]